How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases

A Aigelsreiter1, E Janig, C Stumptner

  • 1Institute of Pathology, Medical University of Graz, Graz, Austria.

Insights

Defective protein folding causes diseases like Alzheimer's and liver conditions. This review explores common pathogenic principles and cellular defense mechanisms in protein aggregation diseases.

Area of Science:

  • Molecular Biology
  • Pathology
  • Cell Biology

Background:

  • Defective protein folding underlies diverse diseases, including neurodegenerative and chronic liver conditions.
  • Common pathogenetic principles link these disorders, stemming from cellular inability to manage misfolded proteins.
  • Protein aggregation diseases arise from cellular failures in preventing misfolding, refolding, or degrading aberrant proteins.

Purpose of the Study:

  • To highlight general pathogenic principles of protein aggregation diseases.
  • To discuss cellular defense mechanisms in protein quality control.
  • To examine pathogenesis in the context of alcoholic and nonalcoholic steatohepatitis.

Main Methods:

  • Immunohistochemical studies
  • Biochemical studies
  • Observations in a mouse model for protein aggregation

Main Results:

  • Evidence for common pathogenetic principles in diverse protein misfolding diseases.
  • Identification of cellular defense mechanisms crucial for protein quality control.
  • Insights into the pathogenesis of protein aggregation diseases, including steatohepatitis.

Conclusions:

  • Cellular dysfunction in protein quality control is a central mechanism in protein aggregation diseases.
  • Understanding these principles aids in comprehending diseases like Alzheimer's, Parkinson's, and various liver conditions.
  • Further research into cellular defense and pathogenesis can inform therapeutic strategies.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA molecules by RNA...